endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India

October 22, 2020

Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...

Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”

April 10, 2020

“We spent hundreds of rupees in private health clinics to trying to cure my tuberculosis, but none of the medication worked. The treatment included daily painful injections with lots of side-effects like vomiting, fatigue, loss of appetite… and sometimes even...

World Tuberculosis Day: Treating the untreatable

March 24, 2019

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...

Providing medical care for drug-resistant tuberculosis in Mumbai

February 12, 2019

MSF in South Asia: Projects in South Asia Access campaign Connect with us UPDATEMédecins Sans Frontières (MSF)/Doctors Without Borders has closed its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project in December 2024. This significant initiative has been providing comprehensive care to patients...

Mumbai: A new life with new tuberculosis drugs

December 1, 2016

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...